Infollion Research Services Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Infollion Research Services Ltd is ₹ 291.15 as of 20 Mar 15:30 . The P/E Ratio of Infollion Research Services Ltd is 21.7 as of March 2024 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2024 . The Market Cap of Infollion Research Services Ltd is ₹ 185.53 crore as of March 2024 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Infollion Research Services Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Infollion Research Services Ltd

Infollion Research Services Limited was formerly incorporated as a Private Company in the name of ' Infollion Research Services Private Limited' dated September 09, 2009, issued by the RoC, Delhi & Haryana.
The Company converted into a Public Company and name of the Company was changed to 'Infollion Research Services Limited' vide a fresh Certificate of Incorporation issued by the RoC, Delhi on October 12, 2022. The Company is a tech-oriented marketplace, operating in the B2B Human Cloud segment, catering to on-demand contingent hiring and work arrangements with senior management talent, subject matter experts, independent consultants and high-ranking, seasoned professionals.
The Company provide a platform for workers or knowledge providers (gig workers) and employers or knowledge seekers to connect and find synergistic outcomes.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Infollion Research Services Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Infollion Research Services Ltd or Sheel Biotech Ltd?

Market cap of Infollion Research Services Ltd is 282 Cr while Market cap of Sheel Biotech Ltd is 99 Cr

What are the key factors driving the stock performance of Infollion Research Services Ltd and Sheel Biotech Ltd?

The stock performance of Infollion Research Services Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Infollion Research Services Ltd and Sheel Biotech Ltd?

As of March 22, 2026, the Infollion Research Services Ltd stock price is INR ₹291.15. On the other hand, Sheel Biotech Ltd stock price is INR ₹49.05.

How do dividend payouts of Infollion Research Services Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Infollion Research Services Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.